Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells

The complex effects of combined CDki/SPyADI application on arginine-auxotrophic glioblastoma multiforme cells. CDki/SPyADI combination therapy impairs cell proliferation, invasiveness, gene expression, induces mitochondrial impairment, and vacuole formation. Abemaciclib-SPyADI-treatment suppresses D...

Full description

Bibliographic Details
Main Authors: Christin Riess, Katharina del Moral, Adina Fiebig, Philipp Kaps, Charlotte Linke, Burkhard Hinz, Anne Rupprecht, Marcus Frank, Tomas Fiedler, Dirk Koczan, Sascha Troschke-Meurer, Holger N. Lode, Nadja Engel, Thomas Freitag, Carl Friedrich Classen, Claudia Maletzki
Format: Article
Language:English
Published: Nature Publishing Group 2022-06-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05006-1
_version_ 1811243866536280064
author Christin Riess
Katharina del Moral
Adina Fiebig
Philipp Kaps
Charlotte Linke
Burkhard Hinz
Anne Rupprecht
Marcus Frank
Tomas Fiedler
Dirk Koczan
Sascha Troschke-Meurer
Holger N. Lode
Nadja Engel
Thomas Freitag
Carl Friedrich Classen
Claudia Maletzki
author_facet Christin Riess
Katharina del Moral
Adina Fiebig
Philipp Kaps
Charlotte Linke
Burkhard Hinz
Anne Rupprecht
Marcus Frank
Tomas Fiedler
Dirk Koczan
Sascha Troschke-Meurer
Holger N. Lode
Nadja Engel
Thomas Freitag
Carl Friedrich Classen
Claudia Maletzki
author_sort Christin Riess
collection DOAJ
description The complex effects of combined CDki/SPyADI application on arginine-auxotrophic glioblastoma multiforme cells. CDki/SPyADI combination therapy impairs cell proliferation, invasiveness, gene expression, induces mitochondrial impairment, and vacuole formation. Abemaciclib-SPyADI-treatment suppresses DNA repair, dinaciclib-SpyADI-treatment enhances γ-H2AX accumulation and activates the stress sensor GADD45 and β-catenin antagonist AXIN2. Both CDKi/SpyADI combinations significantly boost cell death.
first_indexed 2024-04-12T14:14:45Z
format Article
id doaj.art-e4a237d57e9d4704bd9c0f69a431ba27
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-12T14:14:45Z
publishDate 2022-06-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-e4a237d57e9d4704bd9c0f69a431ba272022-12-22T03:29:46ZengNature Publishing GroupCell Death and Disease2041-48892022-06-0113611410.1038/s41419-022-05006-1Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cellsChristin Riess0Katharina del Moral1Adina Fiebig2Philipp Kaps3Charlotte Linke4Burkhard Hinz5Anne Rupprecht6Marcus Frank7Tomas Fiedler8Dirk Koczan9Sascha Troschke-Meurer10Holger N. Lode11Nadja Engel12Thomas Freitag13Carl Friedrich Classen14Claudia Maletzki15University Children’s Hospital, Rostock University Medical CenterUniversity Children’s Hospital, Rostock University Medical CenterInstitute for Medical Microbiology, Virology, and Hygiene, Rostock University Medical CenterUniversity Children’s Hospital, Rostock University Medical CenterUniversity Children’s Hospital, Rostock University Medical CenterInstitute for Pharmacology and Toxicology, Rostock University Medical CenterInstitute for Pharmacology and Toxicology, Rostock University Medical CenterMedical Biology and Electron Microscopy Center, Rostock University Medical CenterInstitute for Medical Microbiology, Virology, and Hygiene, Rostock University Medical CenterInstitute for Immunology, University of RostockDepartment of Pediatric Oncology and Hematology, University Medicine Greifswald, Ferdinand-Sauerbruch-StrasseDepartment of Pediatric Oncology and Hematology, University Medicine Greifswald, Ferdinand-Sauerbruch-StrasseDepartment of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical CenterDepartment of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical CenterUniversity Children’s Hospital, Rostock University Medical CenterDepartment of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical CenterThe complex effects of combined CDki/SPyADI application on arginine-auxotrophic glioblastoma multiforme cells. CDki/SPyADI combination therapy impairs cell proliferation, invasiveness, gene expression, induces mitochondrial impairment, and vacuole formation. Abemaciclib-SPyADI-treatment suppresses DNA repair, dinaciclib-SpyADI-treatment enhances γ-H2AX accumulation and activates the stress sensor GADD45 and β-catenin antagonist AXIN2. Both CDKi/SpyADI combinations significantly boost cell death.https://doi.org/10.1038/s41419-022-05006-1
spellingShingle Christin Riess
Katharina del Moral
Adina Fiebig
Philipp Kaps
Charlotte Linke
Burkhard Hinz
Anne Rupprecht
Marcus Frank
Tomas Fiedler
Dirk Koczan
Sascha Troschke-Meurer
Holger N. Lode
Nadja Engel
Thomas Freitag
Carl Friedrich Classen
Claudia Maletzki
Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
Cell Death and Disease
title Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
title_full Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
title_fullStr Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
title_full_unstemmed Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
title_short Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
title_sort implementation of a combined cdk inhibition and arginine deprivation approach to target arginine auxotrophic glioblastoma multiforme cells
url https://doi.org/10.1038/s41419-022-05006-1
work_keys_str_mv AT christinriess implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT katharinadelmoral implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT adinafiebig implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT philippkaps implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT charlottelinke implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT burkhardhinz implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT annerupprecht implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT marcusfrank implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT tomasfiedler implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT dirkkoczan implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT saschatroschkemeurer implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT holgernlode implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT nadjaengel implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT thomasfreitag implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT carlfriedrichclassen implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells
AT claudiamaletzki implementationofacombinedcdkinhibitionandargininedeprivationapproachtotargetarginineauxotrophicglioblastomamultiformecells